Inhibition of Osteoclastogenesis for Periprosthetic Osteolysis Therapy Through the Suppression of P38 Signaling by Fraxetin
International Journal of Molecular Medicine- Greece
doi 10.3892/ijmm.2018.3698
Full Text
Abstract
Available in
Date
May 21, 2018
Authors
Publisher
Spandidos Publications